Viant San Antonio, Inc.
Form 483 issued March 19, 2026 · Texas
- Inspection
- Mar 16 – Mar 19, 2026
- Investigators
- Katherine M. Thames· Richard T. Riggie
- Observations
- 1
- Pages
- 4
- FEI number
- 3003640911
In short: On March 19, 2026, FDA issued a Form 483 with 1 observation to Viant San Antonio, Inc. in Texas (FEI 3003640911) after an inspection that ran Mar 16 – Mar 19, 2026. The investigators were Katherine M. Thames and Richard T. Riggie. The most-cited regulation is 21 CFR 7.1 (scope).
What FDA observed
Preview: the opening words of each observation- 01ISO 13485:2016 Clause 7.1
In product realization planning your firm did not adequately determine, as appropriate, required activities specific to…
This inspection in context
Katherine M. Thames
6 documents · 2025–2026
Cites 820.198(a) (complaint files) more than any other section. Most of their documents are for sites in Texas.
The firmViant San Antonio, Inc. history
The site's inspection history, in date order.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at Viant San Antonio, Inc.?
FDA listed 1 observation on this Form 483. The most-cited regulation is 21 CFR 7.1 (scope). The opening words of each observation are shown on this page.
Who inspected Viant San Antonio, Inc.?
Katherine M. Thames and Richard T. Riggie are named on this Form 483, for the inspection of Mar 16 – Mar 19, 2026. Each investigator has a profile showing what they cite most.
When was Viant San Antonio, Inc. inspected by FDA?
The inspection ran Mar 16 – Mar 19, 2026, and the Form 483 is dated March 19, 2026.
How do I get the full Form 483 for Viant San Antonio, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.